The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 14.50 (4.97%)
Spread: 0.50 (0.162%)
Open: 298.00
High: 308.00
Low: 285.50
Prev. Close: 291.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adrian Whitfield to step down as CEO

1 Jul 2014 07:00

RNS Number : 9651K
Synthomer PLC
01 July 2014
 



July 1st 2014

Adrian Whitfield to step down as Group Chief Executive in June 2015

Synthomer plc ('Synthomer' or the 'Company') today announces that Adrian Whitfield, Group Chief Executive, will step down after eight years with the Company. To allow sufficient time for a replacement to be found and an orderly transition to take place, Adrian will remain as Group Chief Executive and on the Board until 30 June 2015.

 

The Board will conduct a comprehensive search for the Company's next Chief Executive and a further announcement will be made in due course.

Neil Johnson, Chairman, said: "Over the past 8 years, Adrian has overseen Synthomer's transformation from a small, diversified chemical business to a world leading producer of aqueous polymers. He led the highly successful acquisition of PolymerLatex in 2011 and during his tenure the Company's revenues have more than doubled to over £1 billion.

 

Today the business has a robust balance sheet, strong cashflow and excellent management team. On behalf of the board, I would like to thank Adrian for his hard work and commitment. We are sorry to see him go and wish him all the best for the future."

Adrian Whitfield said:

 

"The 8 years that I have spent with Synthomer have been among the most rewarding of my career. I am proud of the significant turnaround that has been achieved and our track record of strong growth. I have been fortunate to work with a fantastic team and Synthomer's dedicated employees around the world.

 

With the business on a solid platform supported by a clear strategy for future growth, now is the right time in my career to step down and allow someone else to take Synthomer forward. While I remain completely focused on the job until my successor is in place, my thanks go to the Board and everyone at Synthomer for supporting me in leading the Company through such a successful period of its development."

 

 

Enquiries:

 

Synthomer plc

Neil Johnson, Chairman

 

Adrian Whitfield, Group Chief ExecutiveDavid Blackwood, Chief Financial Officer

 

 

 

 

+44 (0) 20 3603 5220 (c/o Pendomer)

 

+44 (0) 1279 442791

Pendomer CommunicationsCharles Armitstead

 

+44 (0) 20 3603 5224

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEASKEDAPLEFF
Date   Source Headline
5th Aug 20221:20 pmRNSHolding(s) in Company
5th Aug 202211:27 amRNSDirector/PDMR Shareholding
4th Aug 20222:57 pmRNSDirector/PDMR Shareholding
4th Aug 20222:35 pmRNSDirector/PDMR Shareholding
3rd Aug 202212:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSResults for the six months ended 30 June 2022
15th Jul 20222:32 pmRNSHolding(s) in Company
8th Jul 202210:23 amRNSHolding(s) in Company
1st Jul 20227:00 amRNSChief Financial Officer
30th Jun 20225:04 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSAppointment of Non-Executive Director
17th May 202212:55 pmRNSHolding(s) in Company
5th May 202212:39 pmRNSHolding(s) in Company
4th May 20224:46 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSAppointment of Joint Corporate Brokers
28th Apr 202212:24 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 2022 trading update
26th Apr 20229:33 amRNSHolding(s) in Company
20th Apr 20224:13 pmRNSHolding(s) in Company
5th Apr 20224:18 pmRNSDirector/PDMR Shareholding
1st Apr 20221:34 pmRNSCompletion of adhesives acquisition
29th Mar 20223:17 pmRNSHolding(s) in Company
29th Mar 20223:14 pmRNSDirector/PDMR Shareholding
25th Mar 20222:03 pmRNSAnnual Financial Report
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:48 pmRNSDirector/PDMR Shareholding
14th Mar 20229:35 amRNSHolding(s) in Company
9th Mar 202212:52 pmRNSDirector/PDMR Shareholding
8th Mar 20223:22 pmRNSDirector/PDMR Shareholding
8th Mar 20223:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSPreliminary Results for the year ended 31 Dec 2021
14th Feb 20227:00 amRNSPre-close trading update
10th Feb 20223:10 pmRNSNOTIFICATION OF MAJOR HOLDINGS
22nd Dec 20215:10 pmRNSDirector/PDMR Shareholding
21st Dec 20213:09 pmRNSDirector/PDMR Shareholding
20th Dec 20213:40 pmRNSDirector/PDMR Shareholding
17th Dec 202112:29 pmRNSResults of General Meeting
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration
11th Nov 20212:24 pmRNSDirector/PDMR Shareholding
4th Nov 20212:11 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSNew Chief Executive
28th Oct 20213:17 pmRNSResult of Placing
28th Oct 20217:00 amRNSAcquisition
28th Oct 20217:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
30th Sep 20213:08 pmRNSDirectorate Change
10th Sep 20218:23 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.